AI-Powered Lab-on-a-Chip May Enable Same-Day Treatment Decisions for Kids With Aggressive Leukemia
University of Utah researchers created an AI-driven lab-on-a-chip to predict therapy sensitivity in pediatric T-ALL, potentially allowing same-day treatment choices.
Scientists at the University of Utah have developed a "lab-on-a-chip" device that combines artificial intelligence to rapidly predict how cancer cells from children with T-cell acute lymphoblastic leukemia (T-ALL) respond to targeted therapies. The platform aims to help clinicians make treatment decisions within the same day for this aggressive and difficult-to-treat pediatric cancer. This report is based on a Medical Xpress news article (https://medicalxpress.com/news/2026-03-ai-powered-lab-chip-platform.html) and does not include details on whether the work was published in a peer-reviewed journal, the sample size used in testing, study design (e.g., RCT versus observational), or any potential conflicts of interest.
VITALIS: For families dealing with a child's leukemia diagnosis, this could mean starting the right treatment within hours instead of days or weeks of uncertainty, while showing how AI is quietly moving from labs into tools that give doctors faster, more personalized insights.
Sources (1)
- [1]AI-powered 'lab-on-a-chip' platform may enable same-day treatment decisions for pediatric patients(https://medicalxpress.com/news/2026-03-ai-powered-lab-chip-platform.html)